Carlos F. Barbas III
American chemist / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Carlos F. Barbas III?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Carlos F. Barbas III (5 November 1964 – 24 June 2014) was chair professor of the Janet and Keith Kellogg II and a chemist at the Scripps Research Institute.[2] Barbas developed new therapies that can target HIV-1 and some kinds of cancer which went into clinical trials.[3]
Quick Facts Born, Died ...
Carlos F. Barbas III | |
---|---|
Born | (1964-11-05)November 5, 1964 |
Died | June 24, 2014(2014-06-24) (aged 49) |
Alma mater | Eckerd College Texas A&M University Pennsylvania State University |
Scientific career | |
Fields | Synthetic organic chemistry Bio-therapeutics |
Institutions | The Scripps Research Institute |
Thesis | Overproduction and utilization of enzymes in synthetic organic chemistry. (1989) |
Doctoral advisor | Chi-Huey Wong |
Other academic advisors | Stephen J. Benkovic |
Notable students | Benjamin List[1] |
Close